CompaniesImpax Pharmaceuticals

Impax Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

204

By Phase

NA: 1PHASE2: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
Today
NCT00721305
NCT01750255
Hover over trial bars to see details

Recent Trials

NCT01750255Collaborator
Effect of Pharmaceutical Care in Patients With Bipolar I Disorder (BD I)
NACompleted
92 participants
Started: Nov 30, 2011 · Completed: Jun 30, 2014
NCT00721305Collaborator
Lovastatin: Immunomodulatory Value Evaluation
PHASE2Completed
112 participants
Started: Aug 31, 2008 · Completed: Jul 31, 2011
Related Companies
Global Pharmaceuticals To Become Impax Laboratories
merged
Impax Pharmaceuticals | Biotech Hunter | Biotech Hunter